Literature DB >> 331132

Acute effect of delta1-tetrahydrocannabinol on the hypothalamo-pituitary-ovarian axis in the rat.

D Ayalon, I Nir, T Cordova, S Bauminger, M Puder, Z Naor, R Kashi, U Zor, A Harell, H R Lindner.   

Abstract

Administration of delta1-tetrahydrocannabinol (delta1-THC), the principal psychoactive ingredient of cannabis, to proestrous rats (2 mg/rat, i.p., between 12.00 and 16.00 h) suppressed the proestrous rise in the plasma levels of LH, FSH and prolactin (Prl) and caused a 24 h delay in ovulation. Furthermore, the increased accumulation of prostaglandins of the E-type (PGE) in the ovaries, normally seen on the evening of proestrus, was prevented. Earlier (08.00-10.30 h) or later (18.00 h) administration of the drug on the day of proestrus was only partially effective in inhibiting ovulation. The suppressive effects of delta1-THC on ovulation and gonadotropin secretion were prevented by administration of gonadetropin releasing hormone (GnRH, 0.2 microgram/rat) 1 h after the drug, indicating that the central action of delta1-THC was exerted on the hypothalamus and not on the pituitary gland. Administration of ovine luteinizing hormore (oLH, 2.5 microgram/rat at 16.30 h on the day of proestrus restored ovulation and ovarian PGE accumulation in Nembutal-treated rats, but not in delta1-THC-treated rats; higher doses of oLH (5-10 microgram/rat) reversed the action of delta1-THC on these two parameters.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 331132     DOI: 10.1159/000122652

Source DB:  PubMed          Journal:  Neuroendocrinology        ISSN: 0028-3835            Impact factor:   4.914


  12 in total

1.  Effect of acute administration of delta 1-tetrahydrocannabinol on beta-endorphin levels in plasma and brain tissue of the rat.

Authors:  V M Wiegant; C G Sweep; I Nir
Journal:  Experientia       Date:  1987-04-15

2.  Effects of tetrahydrocannabinol on rat preovulatory follicles: a quantitative cytochemical analysis.

Authors:  L C Zoller
Journal:  Histochem J       Date:  1985-12

3.  Regulation of gonadotropin-releasing hormone secretion by cannabinoids.

Authors:  C Michael Gammon; G Mark Freeman; Weihua Xie; Wihua Xie; Sandra L Petersen; William C Wetsel
Journal:  Endocrinology       Date:  2005-07-14       Impact factor: 4.736

Review 4.  Impact of cannabinoids on pregnancy, reproductive health, and offspring outcomes.

Authors:  Jamie O Lo; Jason C Hedges; Guillermina Girardi
Journal:  Am J Obstet Gynecol       Date:  2022-05-31       Impact factor: 10.693

5.  Evaluation of sex differences in cannabinoid dependence.

Authors:  Julie A Marusich; Timothy W Lefever; Kateland R Antonazzo; Rebecca M Craft; Jenny L Wiley
Journal:  Drug Alcohol Depend       Date:  2014-02-12       Impact factor: 4.492

6.  Menstrual Cycle in Women Who Co-use Marijuana and Tobacco.

Authors:  Sara Lammert; Katherine Harrison; Nicole Tosun; Sharon Allen
Journal:  J Addict Med       Date:  2018 May/Jun       Impact factor: 3.702

7.  The effect of delta 1tetrahydrocannabinol on luteinizing hormone release in castrated and hypothalamic deafferented male rats.

Authors:  M Puder; I Nir; R A Siegel; J Weidenfeld; D Ayalon
Journal:  Exp Brain Res       Date:  1985       Impact factor: 1.972

8.  Pituitary function following treatment with reproductive toxins.

Authors:  R L Cooper; J M Goldman; G L Rehnberg
Journal:  Environ Health Perspect       Date:  1986-12       Impact factor: 9.031

9.  Retrograde endocannabinoid signaling reduces GABAergic synaptic transmission to gonadotropin-releasing hormone neurons.

Authors:  Imre Farkas; Imre Kalló; Levente Deli; Barbara Vida; Erik Hrabovszky; Csaba Fekete; Suzanne M Moenter; Masahiko Watanabe; Zsolt Liposits
Journal:  Endocrinology       Date:  2010-10-06       Impact factor: 4.736

10.  Localisation and function of the endocannabinoid system in the human ovary.

Authors:  Mona R El-Talatini; Anthony H Taylor; Janine C Elson; Laurence Brown; Allan C Davidson; Justin C Konje
Journal:  PLoS One       Date:  2009-02-24       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.